SRRK Stock Analysis: Buy, Sell, or Hold?

SRRK - Scholar Rock Holding Corporation Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$54.70
-2.01 (-3.54%) ▼
5d: -1.19%
30d: +24.06%
90d: +9.49%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026 21d

Get Alerted When SRRK Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: SRRK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SRRK is currently trading at $54.70, which is considered slightly high relative to its 30-day fair value range of $45.66 to $55.42.

Technical Outlook: Technically, SRRK is in a uptrend. Immediate support is located at $51.32, while resistance sits at $58.49. Short-term momentum is weak, with the stock down 3.5% recently.

Market Sentiment: SRRK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $45.66 - $55.42
Company Quality Score 62/100 (BUY)
Volume Confirmation HIGH
Confidence Score 68.4%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.5%)
  • NEUTRAL: Near Wall St target ($59.31)

Trading Range Analysis

30-Day Trading Range $45.66 - $55.42
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $51.32
Resistance Level $58.49
Current Trend Uptrend
Technical data as of Jul 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) -21.43
Wall Street Target $59.31 (+8.4%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 14, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
David Hallal SELL 30615 shares 2026-04-16
Keith Woods SELL 10220 shares 2026-04-16
Vikas Sinha SELL 10410 shares 2026-04-16

Unlock Insider Activity

See real-time buying/selling by company executives for SRRK.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$413 54 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 54 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 55 HOLD
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$41 59 HOLD

Advanced SRRK Option Strategies

Professional options setups generated by AI based on today's SRRK price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SRRK

SRRK Technical Chart SRRK Price Prediction SRRK Earnings Date SRRK Investment Advisor SRRK Fair Price Analyzer SRRK Options Advisor SRRK Options Chain SRRK Options Analysis SRRK Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals